Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #121953

Stanley H. Weiss, MD¹, Judith B. Klotz, DrPH², Xiaoling Niu, MS³, Jung Yee Kim, MPH⁴, and Daniel M. Rosenblum, PhD⁴. (1) Epidemiology, UMDNJ-New Jersey Medical School, 30 Bergen St, Bldg 16, Suite ADMC 1614, Newark, NJ 07107-3000, (2) UMDNJ-School of Public Health, 30 Bergen Street, ADMC 16, Suite 1614, Newark, NJ 07107-3000, 973-972-4623, judith.klotz@comcast.net, (3) Cancer Epidemiology Services, New Jersey Department of Health and Senior Services, P.O. Box 369, Trenton, NJ 08625-0369, (4) Preventive Medicine & Community Health, UMDNJ-New Jersey Medical School, 30 Bergen Street, ADMC 16, Suite 1614, Newark, NJ 07107-3000

In order to estimate the county burdens of certain common cancers, we generated a simple method for estimating county-specific total prevalence counts. The method requires only the following data: (1) county incidence counts from state cancer registries; (2) county census; (3) national crude incidence rates from SEER (NCI), and (4) national prevalence estimates from SEER. For total prevalence, all cancer survivors are counted as prevalent cases, regardless of elapsed time since diagnosis, because the sequelae of many cancer treatments and the psychosocial effects of cancer diagnoses and survival often result in lifelong healthcare services for patients and their families. We made simplifying assumptions about variations in survival rates, racial/ethnic distributions, and migration. The core of the method involves calculation of ratios of prevalence counts to incidence counts. These ratios varied from 1.4 (lung cancer in males) to 17.0 (cervical cancer). We compare these estimates with limited-duration prevalence estimates from other sources, by cancer type. Capacity and needs assessments conducted in each New Jersey county were able to incorporate and use these estimates for their analyses and summaries for cancer control.

Learning Objectives: Learning Objectives

At the conclusion of the session, the participant will be able to (
• Identify key components of a state comprehensive cancer control plan. (
• Assess the feasibility of and resources needed for conducting a comprehensive cancer capacity and needs assessment from an epidemiologic standpoint. (
• Describe strategies to expand partnerships with state and local cancer control planners. (
• Describe benefits and limitations of local implementation approaches. (
• Be able to apply a simplified methodology to develop prevalence estimates. (
• Better understand issues related to cancer disparities in Latino communities.

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.

Handout (.ppt format,

Recorded presentation